Cargando…
Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review()
BACKGROUND: Capecitabine (Xeloda®) is a cytotoxic, antimetabolite chemotherapeutic agent. Its most common adverse events are diarrhea, hand-foot syndrome (HFS), hyperbilirubinemia, hyperpigmentation, fatigue, abdominal pain, and other gastrointestinal effects. HFS or palmar-plantar erythrodysesthesi...
Autores principales: | Nascimento, Anna Danielly Almeida do, Porto, Débora Maria, Vidal, Aurora Karla de Lacerda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173070/ https://www.ncbi.nlm.nih.gov/pubmed/36803558 http://dx.doi.org/10.1016/j.abd.2022.05.004 |
Ejemplares similares
-
Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?
por: Caprez, Jennifer, et al.
Publicado: (2018) -
An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?
por: Vasudevan, Biju
Publicado: (2010) -
Oral hyperpigmentation as an initial clinical aspect of hand foot
syndrome
por: dos Santos-Leite, Éder Gerardo, et al.
Publicado: (2022) -
Oral mucosal hyperpigmentation
por: Lee, Karen, et al.
Publicado: (2020) -
HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2009)